Nike Beats on Earnings But Struggles in China and Faces Tariffs

Nike reported revenue of $12.4 billion in the latest quarter, up 1% (flat on a currency-neutral basis) and beating consensus of just under $12.2 billion, while diluted EPS was $0.53 (down 32% year-over-year) versus Street expectations of $0.38. Gross margin compressed 300 basis points to 40.6% largely from tariff headwinds; management expects next-quarter revenue to decline low single digits and sees gross margin falling about 200 basis points at the midpoint. Regionally, North America grew 9% but Greater China sales plunged 16% and Nike Direct Digital sales dropped 14% (China Direct down 36%), even as the running product line grew 20%; after-hours shares fell nearly 10% on the cautious guidance and slow recovery execution. Management is pursuing a Sport Offense reorganization and measures to reduce tariff impact, but persistent China, DTC, and margin pressures leave the recovery path uncertain.

Analysis

Market structure: Nike’s pullback (≈34% over 3 years; after-hours -10% on Dec 18) redistributes short-term share to specialty runners (ON/ONON) and wholesale partners (Foot Locker) as Nike’s DTC stumble (-14% overall; -36% China) reduces shelf visibility. Tariffs (-300bps GM last quarter; guidance -200bps next quarter; target -120bps relief by FY2026) and excess inventory imply continued margin pressure and increased promotional activity, pressuring ASPs and elevating volatility in FY26 planning.

Competitive dynamics: Sport Offense and running (+20% sales) are a tactical bright spot but early-stage; if executed, Nike can regain pricing power in core categories over 12–24 months, but failure to reset China e‑commerce quickly (sales -16% Greater China) risks permanent share loss to domestic players. Expect winners in nimble niche brands (ONON) and retailers capturing diverted demand; incumbents with heavy China exposure are vulnerable.

Risk profile & catalysts: Near-term catalysts are next-quarter revenue guide, tariff resolution, and China strategy announcements (0–3 months); medium-term catalysts are product cadence and gross margin recovery targets into FY2026 (12–24 months). Tail risks: tariff escalation, a deeper China consumer downturn, or accelerated inventory-driven discounting could trigger >20% downside from current levels; activist involvement or supply-chain re-shoring are upside structural catalysts.

Cross-asset & second-order effects: Weakness in NKE nudges consumer discretionary spreads wider, lifts equity implied vol and could modestly pressure IG funding if consumer names rerate; USD/GBP/CNY moves matter — a weaker CNY would further depress Chinese revenue in USD terms. Short-dated options volatility is elevated; bond markets will price credit via retail margin stress if the selloff broadens.

Key Decisions for Investors

• Short-term tactical: Buy a 45–75 day NKE put spread (e.g., 1x 62.5/52.5 if available) sized to 0.5–1.0% portfolio risk to capture continued post-earnings downside and elevated IV; target spread P&L +3x cost or close if NKE < $50 within 2 months.
• Medium-term contrarian: Accumulate a 1.5–3.0% core long in NKE using calendar-buying: purchase Dec 2026 LEAP calls (strike 65) in tranches if NKE trades below $55, targeting 25–40% upside by FY2026 as tariffs abate and running/Sport Offense scale; cap total option spend to 1–2% of portfolio.
• Pair trade (relative value): Go long ONON (2% position) and short NKE (2% position) equal dollar for 6–12 months to capture product-innovation/market-share rotation; rebalance if ONON underperforms by >15% or NKE reports clear China turnaround.
• Sector rotation: Reduce apparel-heavy consumer discretionary exposure by 3–5% in favor of defensive consumer staples/fitness equipment (e.g., small overweight to GLD or selective HYG allocations) until tariff clarity or China demand stabilizes (monitor tariffs & China PMI over next 60 days).